CANCER BUZZ PODCAST

Improving timely identification and referral of patients who may be eligible for chimeric antigen receptor (CAR) T-cell therapy is critical for improving outcomes for patients with hematologic malignancies.

In this episode, Alessandro Villa, DDS, PhD, MPH, chief of Oral Medicine, Oral Oncology, and Dentistry at Baptist Health South Florida’s Miami Cancer Institute, emphasizes the proactive role dentists can play in early identification of cancer

CANCER BUZZ speaks with Aaron Cumpston, PharmD, and Christine Barrett, PharmD, BCOP, who discuss the challenges of care coordination and therapy and share operational best practices for the delivery of bispecific antibodies in the community setting.

In this episode, CANCER BUZZ speaks with Linda Hayward, patient financial advocate at the University of Maryland, Kaufman Cancer Center at Upper Chesapeake Health

Recent advancements in treatment and a multimodal approach to care are improving outcomes for patients with head and neck cancer, however access to therapies and unique patient challenges and other psychosocial factors can reduce patient quality of life.

CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.

In this episode, CANCER BUZZ speaks with David L. Porter, MD, director of Cell Therapy and Transplant at Penn Medicine.

Listen as we discuss germline and somatic testing for patients with ovarian cancer.

Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients.

Disparities in bladder cancer care persist, especially with respect to race. In fact, patient demographics has a proven impact on health outcomes.

CANCER BUZZ speaks with Farrukh T. Awan, MD, MS about an approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia.

CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology about strategies to optimize critical conversations with patients with acute myeloid leukemia.

In this episode, CANCER BUZZ speaks about strategies to address these disparities and optimize care and treatment options for patients with acute myeloid leukemia who do not receive a transplant.

As myeloproliferative neoplasms (MPNs) carry a heavy symptom burden which can significantly impact a patient’s quality of life, hear how multidisciplinary care and psycho-social support can help alleviate this burden for patients.

The goal of treatment for most patients with myelofibrosis is to relieve symptoms. Hear Dr. Gerds discuss standard of care treatment options and new therapies for treating patients with myelofibrosis.

Tune-in as Dr. Hobbs discusses symptom scoring, risk stratification, and effective practices in building a strong myelofibrosis program.

Listen as Cindy Varga, MD, discusses the positives and negatives with subcutaneous versus intravenous drugs in treating patients with multiple myeloma.

Learn how recent guideline and treatment options by the National Comprehensive Cancer Network (NCCN) can optimize care for patients with MPNs.

MPNs carry a significant symptom burden and oftentimes can require lifelong care. Hear how a strong multidisciplinary approach can impact shared decision-making and patient engagement.

Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant. Listen as Dr. Yee provides treatment planning options to patients who are ineligible for transplant.